Otto, M., Krebs, J., Welker, P., Holm, R., Thiel, M., Gattinoni, L., . . . Tsagogiorgas, C. (2021). Inhalationally administered semifluorinated alkanes (SFAs) as drug carriers in an experimental model of acute respiratory distress syndrome. Pharmaceutics, 13(3), . https://doi.org/10.3390/pharmaceutics13030431
Chicago-Zitierstil (17. Ausg.)Otto, Matthias, Jörg Krebs, Peter Welker, René Holm, Manfred Thiel, Luciano Gattinoni, Michael Quintel, und Charalambos Tsagogiorgas. "Inhalationally Administered Semifluorinated Alkanes (SFAs) as Drug Carriers in an Experimental Model of Acute Respiratory Distress Syndrome." Pharmaceutics 13, no. 3 (2021). https://doi.org/10.3390/pharmaceutics13030431.
MLA-Zitierstil (9. Ausg.)Otto, Matthias, et al. "Inhalationally Administered Semifluorinated Alkanes (SFAs) as Drug Carriers in an Experimental Model of Acute Respiratory Distress Syndrome." Pharmaceutics, vol. 13, no. 3, 2021, https://doi.org/10.3390/pharmaceutics13030431.